This inventor holds 1 USPTO granted patent. Top assignee: Angiolab, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Ki-Hwan Bae in Angiogenesis and Radiosensitization
Introduction
Ki-Hwan Bae, an accomplished inventor based in Taejon, South Korea, has made significant strides in the fields of angiogenesis and radiosensitization through his innovative work. With a focus on developing compositions to enhance therapeutic applications, Bae’s contributions are noteworthy in the realm of medical science.
Latest Patents
Ki-Hwan Bae holds one patent that showcases his inventive prowess. The patent, titled "Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization," pertains to a composition that includes paeonol or its pharmaceutically acceptable salts as an active ingredient. The invention involves a method for inhibiting angiogenesis, which can be crucial in cancer treatment, as well as a technique for enhancing radiosensitization, ensuring that patients undergoing radiotherapy receive optimal benefits from their treatment. This innovative approach has the potential to influence future therapeutic strategies in oncology.
Career Highlights
Bae is currently associated with Angiolab, Inc., a company focused on reducing the burden of angiogenesis-related conditions through innovative solutions. His dedication to research and development in this area positions him as a valuable asset in the biomedical field. Bae's work not only reflects his individual talent but also embodies the commitment of his organization to advancing medical science.
Collaborations
Throughout his career, Ki-Hwan Bae has collaborated with talented professionals including Min-Young Kim and Hee-Suk Lee. These partnerships highlight the collective effort in driving innovative research and developing effective therapeutic interventions, reinforcing the importance of teamwork in achieving significant advancements.
Conclusion
Ki-Hwan Bae's inventive contributions, particularly through his patent focused on paeonol's applications, mark him as a noteworthy inventor in the field of medical innovation. His work has the potential to improve treatment outcomes for patients requiring advanced interventions, showcasing the vital role of inventors in the ongoing quest for scientific and medical advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
